Q3 FY2026 · Quarterly report
Read Alnylam Pharmaceuticals, Inc.'s results firsthand
Preview the first 2 pages of this quarterly report
Create a free account to start reading
Full documents are included with Professional
Alnylam Pharmaceuticals, Inc.
165.00
USD
-9.00
(-5.17%)
